John Carlsen has more than 17 years of experience with coding, coverage, and reimbursement issues in various settings of care. Mr. Carlsen specializes in assessing the impact of changes to Medicare and managed care payment systems on the reimbursement of drugs, biologics, and devices, and has collaborated with manufacturers on market access strategy projects in a variety of therapeutic areas. He has closely followed developments related to biosimilars reimbursement since the enactment of the Affordable Care Act in 2010. Prior to joining Covance, Mr. Carlsen worked at the Ohio State University (OSU) Medical Center in Columbus, Ohio, where he focused on financial management and medical information management issues. Mr. Carlsen received an M.H.A. from OSU’s Graduate Program in Health Services Management and Policy, and a B.A. in Economics with a minor in Psychology from Duke University.